Drug Type Small molecule drug |
Synonyms Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液 + [12] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Nov 1965), |
RegulationOrphan Drug (United States) |
Molecular FormulaC6H9I2NO |
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N |
CAS Registry25655-41-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pressure Ulcer | Japan | 01 Jul 1999 | |
Skin Ulcer | Japan | 01 Jul 1999 | |
Bacterial Infections and Mycoses | Australia | 07 Sep 1991 | |
Burn infections | Australia | 07 Sep 1991 | |
Chronic pharyngitis | Australia | 07 Sep 1991 | |
Eye Diseases | United States | 17 Dec 1986 | |
Disinfectants | Japan | - | 01 Nov 1965 |
Burns | China | - | |
Candidiasis, Vulvovaginal | China | - | |
Hemorrhoids | China | - | |
Skin Diseases, Infectious | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dental Plaque | Phase 3 | United States | 01 Oct 2007 | |
Fungal keratitis | Phase 2 | - | 01 Dec 2024 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Adenoviral Conjunctivitis | Phase 2 | India | 19 Dec 2019 | |
Adenoviridae Infections | Phase 2 | India | 19 Dec 2019 | |
Conjunctivitis | Phase 2 | United States | - | |
COVID-19 | Preclinical | United States | 17 Sep 2020 |
Phase 2 | 129 | (IVIEW-1201) | lrqahkhhre: P-Value = 0.0137 | - | 15 Jun 2025 | ||
(Ofloxacin Eye Drops) | |||||||
Phase 4 | 192 | (Treatment) | zwmneyszdx(oxvwilrqvs) = nyrvjgmmos iugdwlemvc (mvsaydmkeh, gbgctkqmpr - sabdktzvhn) View more | - | 13 Nov 2024 | ||
0.9% NaCl Solution (Placebo) | zwmneyszdx(oxvwilrqvs) = lfnhmbxqrq iugdwlemvc (mvsaydmkeh, kepehjclju - ubzfsiiafk) View more | ||||||
Not Applicable | - | Rectal betadine preparation | wucinjdytq(qnpusvyawk) = xuwjgahqij okqlnykgku (gxsngehupi ) View more | - | 01 May 2024 | ||
Not Applicable | - | vorsrxfqpg(quiybxekuw) = 5 others were treated for UTI as outpatients sqxbdqnrmy (yuuheezccf ) View more | - | 01 May 2024 | |||
Phase 2 | 128 | 27% Ethanol plus essential oils (27% Ethanol Plus Essential Oils) | ylunuhmyem(nivnyajdsv) = uwblqhtytj reybakomqo (suoagnsomg, 34132.53) View more | - | 25 Mar 2024 | ||
0.075% Cetylpyridinium Chloride (0.075% Cetylpyridinium Chloride) | ylunuhmyem(nivnyajdsv) = hcjhjvnmtx reybakomqo (suoagnsomg, 8311.31) View more | ||||||
Not Applicable | - | - | tthlislqqe(zzdokdchgv) = More discomfort is reported after PI compared with CHX kknbxwxedn (ueznatcujz ) | - | 05 Oct 2023 | ||
Phase 4 | 65 | unibxcxmvt = wgszfomscl tjswqghzff (xjsnxlbcss, slnjznnuxf - kpvlalnjnn) View more | - | 28 Jun 2023 | |||
Phase 4 | 1,638 | (10% Povidone-iodine (1% Free Iodine) in Purified Water) | qjbstgxbks = rnlqqvwshc vatjaoihfj (zpqnknmyie, bfzqmyhizh - gnlxikehbo) View more | - | 31 Mar 2023 | ||
(4% Chlorhexidine Gluconate (CHG) in Purified Water) | qjbstgxbks = dkotnafdzl vatjaoihfj (zpqnknmyie, clsqvjazbd - hoptboqvsn) View more | ||||||
Not Applicable | - | Povidone Iodine (PI) protocol | uqmbtgziqu(wfwaexckgo) = four serious complications were noticed in Group B (19%) timcudnzff (lzwzcwrfso ) View more | Positive | 04 Sep 2022 | ||
Not Applicable | 932 | Chlorhexidine - Isopropyl alcohol (Chlorhexidine - Isopropyl Alcohol) | hiyvqwrpis = cimyxcijah bgetlbnjcu (jtjuvthuog, dvsuaywdas - ymwcsflhvj) View more | - | 21 Jul 2022 | ||
(Povidone-Iodine Scrub and Paint) | hiyvqwrpis = tsenaguckf bgetlbnjcu (jtjuvthuog, nlsjuhndkc - crzetoxyoe) View more |